
| Enter Keyword(s): Enter a City: Select a State: Select a Category: |
| - Advanced Job Search |
| - Search by Company |
Monday
Tuesday
Wednesday
Tuesday
February 7, 2012 at 8pm to February 9, 2012 at 5pm – Philadelphia, PA
Tuesday
| 1 |
Subscribe to New Pharma- the magazine for decision makers in a global industryPosted by Pharma Connections Marketing on January 15, 2012 |
| 2 |
Partnership in the middle east & AfricaPosted by ahmed ali on November 25, 2011 |
| 3 |
Call for Speakers! A.L.I.'s 1st Clinical Supply Chain Management Conference, May 15-18 2012.Posted by Angie Coleman on January 12, 2012 |
| 4 |
Is true innovation in pharma and biotech industry measurable?Posted by Mara Der Hovanesian on January 10, 2012 |
| 5 |
GS1 EPCglobal Software Certification Mark Awarded to FastPoint TechnologiesPosted by Soheil Raissi on January 28, 2012 |
Started by Soheil Raissi in Pharmaceutical Distribution & Licensing Opportunities 15 hours ago.
Started by Pharma Connections Marketing in General Discussion Topics. Last reply by min 10 hours ago.
Started by Angie Coleman in General Discussion Topics Jan 12.
Started by Mara Der Hovanesian in General Discussion Topics Jan 10.
Started by Pharma Connections Marketing in Events Listings & Information Dec 29, 2011.
Started by ahmed ali in Contract Research & Manufacturing Opportunities. Last reply by ahmed ali Dec 27, 2011.
Started by ahmed ali in Pharmaceutical Distribution & Licensing Opportunities Dec 10, 2011.
Started by ahmed ali in Pharmaceutical Distribution & Licensing Opportunities. Last reply by ahmed ali Jan 15.
Started by ahmed ali in Business Development Opportunities Nov 24, 2011.
Started by ahmed ali in Pharmaceutical Distribution & Licensing Opportunities Nov 24, 2011.
Posted by Satyakam Chakravarty on September 3, 2009 at 11:29am 0 Comments 0 Favorites
Posted by Steven Bonacorsi on February 16, 2009 at 11:59pm 0 Comments 0 Favorites
Posted by Jagdish Gohil on July 5, 2011 at 4:14am 0 Comments 0 Favorites
We reiterate our Market Perform rating on Astellas following announcement of JP approval for Betanis / mirabegron (β3-AR agonist, overactive bladder syndrome (OAB). Mirabegron is a key…
ContinuePosted by Michael North on September 29, 2009 at 6:47am 0 Comments 0 Favorites